Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

710
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
710
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

299
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
299
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

625
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
625
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

300
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
300
Mitral Regurgitation II: Clinical Features and Diagnostic Tests01:23

Mitral Regurgitation II: Clinical Features and Diagnostic Tests

557
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
557
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

610
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
610

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preclinical safety and performance evaluation of a highly-flexible peripheral polytetrafluoroethylene-covered stent.

Cardiology journal·2025
Same author

The preclinical study of biocompatibility of tyrosine polycarbonate bioresorbable scaffold in small caliber porcine peripheral arteries.

Scientific reports·2025
Same author

Mitochondrial Ca<sup>2+</sup> Uniporter-Dependent Energetic Dysfunction Drives Hypertrophy in Heart Failure.

JACC. Basic to translational science·2024
Same author

Scientific and Regulatory Policy Committee Points to Consider for Medical Device Implant Site Evaluation in Nonclinical Studies.

Toxicologic pathology·2022
Same author

6-Month Evaluation of a Transcatheter Aortic Valve (Myval) in a Novel Ovine, Supra-Aortic Banding Model.

JACC. Basic to translational science·2022
Same author

Chronic myocardial and coronary arterial effects of intracoronary supersaturated oxygen therapy in swine with normal and ischemic-reperfused myocardium.

Scientific reports·2022

Related Experiment Video

Updated: Feb 18, 2026

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.7K

Comprehensive Preclinical Postmortem Evaluation of Valvular Prosthesis.

Armando Tellez1,2, Krista N Dillon1, Serge D Rousselle1

  • 11 Alizée Pathology, Thurmont, MD, USA.

Toxicologic Pathology
|November 18, 2017
PubMed
Summary

Transcatheter prosthetic valves offer new options for high-risk patients. This study introduces a comprehensive pathological evaluation platform for preclinical transcatheter valve testing, ensuring reliable and reproducible results.

Keywords:
MVRTAVIanimal modelpreclinical evaluationvalveµCT

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.8K
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.3K

Related Experiment Videos

Last Updated: Feb 18, 2026

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
06:56

Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies

Published on: August 25, 2023

1.7K
Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

16.8K
Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves
11:12

Protocol for Relative Hydrodynamic Assessment of Tri-leaflet Polymer Valves

Published on: October 17, 2013

14.3K

Area of Science:

  • Interventional Cardiology
  • Biomaterials Science
  • Veterinary Pathology

Background:

  • Transcatheter prosthetic valves are revolutionizing cardiac surgery, expanding treatment to elderly and high-risk patients.
  • Preclinical testing of novel artificial valve designs and delivery systems is increasing.
  • Current pathological evaluation methods for animal models in transcatheter valve implant testing are inadequate.

Purpose of the Study:

  • To present a comprehensive platform for the pathological evaluation of transcatheter valve implants in preclinical settings.
  • To establish a reliable, reproducible, and effective evaluation method for diverse valve types and locations.

Main Methods:

  • Development and implementation of a standardized pathological assessment protocol.
  • Application of the platform across various transcatheter valve designs and implantation sites in animal models.
  • Validation of the platform's reliability and reproducibility.

Main Results:

  • The proposed evaluation platform demonstrates reliability, reproducibility, and effectiveness.
  • The method is applicable to a wide range of transcatheter valve prostheses and anatomical locations.
  • Provides a standardized approach for assessing valve performance and tissue response.

Conclusions:

  • A comprehensive pathological evaluation platform is crucial for advancing transcatheter valve technology.
  • This standardized approach will facilitate rigorous preclinical assessment, improving device safety and efficacy.
  • The platform supports the development of next-generation transcatheter prosthetic valves.